For the first time, serum thymidine kinase 1 protein (STK1p), a tumor cell proliferating biomarker, was combined with ultrasound parameters to construct a novel nomogram model for the clinical prevention of CLNM in PTC pre-surgery. This evidence concerns the gene TK1 and neoplasm.